Our open access, online journal, ESMO Open is now listed in Pubmed Central, only 10-months after launch. Learn more about the journal!
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
Alberto Sobrero, ESMO 2017 Scientific Co-Chair, emphasises the importance of the ESMO 2017 Congress in partnership with the EACR bringing together basic and clinical researchers in light of an integrated approach to cancer care.
27 Jun 2017
In advanced RCC, it is indicated as first line treatment and for patients who are VEGFR and mTOR pathway inhibitor-naive following disease progression...
27 Jun 2017
New eUpdate featuring treatment recommendations and algorithms for Chronic Lymphocytic Leukaemia
26 Jun 2017
In combination with letrozole, it is intended as initial endocrine based treatment of postmenopausal women with HR-positive, HER2-negative locally...
23 Jun 2017
The new Annals of Oncology app is now available to download from iTunes!
23 Jun 2017
FDA also approved the NGS test to detect the presence of BRAF, ROS1, and EGFR gene mutations or alterations in NSCLC tumour tissue
23 Jun 2017
Online registration for Sarcoma and GIST 2018 will be available in September 2017!
Barcelona, Spain
28 Jun
- 01 Jul
2017
Valencia, Spain
13 Jul
- 18 Jul
2017
Oxford, United Kingdom
04 Aug
- 06 Aug
2017
Madrid, Spain
08 Sep
- 12 Sep
2017
Zurich, Switzerland
13 Oct
- 14 Oct
2017
Barcelona, Spain
16 Nov
- 19 Nov
2017
